Radius Assist

The Radius Assist Patient Assistance Program (“Radius Assist”) provides TYMLOS (abaloparatide) injection therapy at no cost to qualified patients in need.

To qualify, patients must meet the eligibility criteria and, along with their healthcare provider, submit all required documentation.

If a patient is accepted into the program, they will receive up to 3 months of medication per shipment, and up to 24 months of therapy.  Acceptance into the program is valid for the current calendar year and with a valid prescription (subject to continued eligibility) and until the patient has reached a total of 24 months of therapy provided by Radius Assist.*

To be eligible for Radius Assist, patients should:

• have an FDA-approved, on-label diagnosis for TYMLOS (abaloparatide) injection;
• be legal residents of contiguous United States, Alaska, Hawaii, or Puerto Rico; and
• have an annual household income of <300% Federal Poverty Limit (visit https://aspe.hhs.gov/poverty-guidelines for information on the Federal Poverty Limit.)

Additional eligibility criteria vary based on the coverage of the patient.

To be eligible for Radius Assist as Medicare beneficiaries, patients must not:

• be enrolled in Medicaid, Tricare, Veterans Health Administration, or Indian Health Service benefit programs;
• be enrolled in full Low-Income Subsidy (LIS) from the Social Security Administration; and
• Patients in NY, PA, or WI must not be eligible for the State Pharmacy Assistance Programs

To be eligible for Radius Assist as a commercially insured patient:

• Patient must have neither insurance coverage for nor access to other coverage for TYMLOS.

To submit, follow the instructions on page 1 of the application.

Once the application is submitted, the healthcare professional will receive a confirmation fax when Radius Assist is in receipt of the application. If information is missing, the Radius Assist team will reach out to the healthcare professional and/or the patient to obtain. As a reminder, all information is required in order for Radius Assist to make a determination on eligibility.

If the application is approved, the healthcare professional will receive notification via fax and the patient will be notified via mail or phone call (based on preference). The patient will then be contacted by the specialty pharmacy providing medication for Radius Assist patients, Medvantx, to coordinate medication shipment.

*Eligibility criteria for the Radius Assist Patient Assistance Program is subject to change at any time. Criteria changes will impact new patients entering the program and those that need to submit re-verifications for the next calendar year. Patients can receive up to, but not exceeding, 24 months of total TYMLOS therapy from Radius Assist. Radius Assist will discontinue providing therapy once the patient’s cumulative lifetime use of TYMLOS has reached 24 months. Use of TYMLOS for more than 2 years during a patient’s lifetime is not recommended.

Radius Assist is a charitable program intended to support patients with genuine financial need, based solely on individual income and other eligibility criteria. The program is not a substitute for health insurance coverage and is not intended to serve as a mechanism for cost-shifting or benefit design by employers, health plans, or other third parties.

Patients are only eligible to participate in Radius Assist if their application is made voluntarily, without coercion, direction, or requirement from any employer, health plan, insurer, or other third-party entity. If an employer, plan, or other third party—directly or indirectly—requires, encourages, incentivizes, or makes application to Radius Assist a condition of, requirement for, or prerequisite to insurance coverage, reimbursement, or benefit design, the individual is ineligible for Radius Assist, regardless of whether financial eligibility criteria are otherwise met.

In addition, if an application to Radius Assist is submitted by or with the involvement of an Alternative Funding Plan (AFP) — defined as any program, vendor, or strategy designed to redirect patients from employer or plan coverage to third-party assistance programs to avoid or reduce plan costs — at the request or direction of such third party, the applicant will be deemed ineligible. This includes, but is not limited to, circumstances where the employer or plan requires, facilitates, or indirectly influences such application through plan design or financial incentives.

Radius Assist may not be used as part of any incentive arrangement or to subsidize coverage obligations otherwise borne by employers, plans, or insurers. Any attempt to circumvent this policy, including through indirect steering, patient guidance, or plan structuring, will be treated as a violation.

Applications that violate these requirements will be blocked from participating in the program. Radius Health reserves the right to audit applications and third-party involvement, terminate participation, and take further action as necessary, including notifying regulatory authorities. This policy is intended to ensure compliance with applicable healthcare fraud, anti-kickback, and charitable assistance regulations.